Profile
Michael A.
Byrne is Chief Financial Officer and Corporate Secretary of Viventia Biotech, Inc. Prior to joining Viventia, he was Chief Financial Officer of Hyal Pharmaceuticals, Inc. Mr. Byrne has over 20 years of executive experience in the biotech and pharmaceutical sector.
Michael A. Byrne active positions
| Companies | Position | Start |
|---|---|---|
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Director of Finance/CFO | 31/12/1999 |
Former positions of Michael A. Byrne
| Companies | Position | End |
|---|---|---|
| Hyal Pharmaceutical Corp. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
| Hyal Pharmaceutical Corp. | Health Technology |
- Stock Market
- Insiders
- Michael A. Byrne
